Abstract
We evaluated the feasibility and efficacy of a commercially available methicillin-resistant Staphylococcus aureus (MRSA)-selective agar, chromID™ MRSA, to detect group B streptococci with reduced penicillin susceptibility (PRGBS) in this study. The results showed 72.4% (21/29) sensitivity and 98.4% (60/61) specificity to detect PRGBS using this method.
Original language | English |
---|---|
Pages (from-to) | 309-312 |
Number of pages | 4 |
Journal | Diagnostic Microbiology and Infectious Disease |
Volume | 85 |
Issue number | 3 |
DOIs | |
Publication status | Published - 01-07-2016 |
Externally published | Yes |
All Science Journal Classification (ASJC) codes
- Microbiology (medical)
- Infectious Diseases